Targeting the undruggable proteome
Captor Therapeutics (captortherapeutics.com) scores 68 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 17th percentile of 14043 Healthcare brands.
Captor Therapeutics is a high-tech pharmaceutical company focused on targeting the undruggable proteome. Using its proprietary Optigrade™ platform, which integrates protein engineering, structural biology, molecular modelling, and CRISPR/Cas9-based genome editing, the company develops novel therapeutics for severe conditions such as cancer and autoimmune diseases through targeted protein degradation. Its work targets investors, scientific partners, and pharmaceutical collaborators interested in innovative drug discovery, as well as patients with unmet medical needs.
| Brand Name | Captor Therapeutics |
|---|---|
| Domain | captortherapeutics.com |
| Industry | Healthcare |
| Main Competitors | Arvinas (80/100), C4 Therapeutics (73/100), Kymera Therapeutics (76/100), Nurix Therapeutics (73/100), Monte Rosa Therapeutics (76/100) |
Moz Domain Authority 32/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Captor Therapeutics is a high-tech pharmaceutical company focused on targeting the undruggable proteome." (Meta description: 13 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx.
Social footprint: verified profiles on X (Twitter), Instagram; no detected presence on LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Captor Therapeutics?", Claude could identify the brand as of October 2026. Captor Therapeutics is a Polish-Swiss biotech company focused on developing targeted protein degradation therapies, particularly using proteolysis-targeting chimeras (PROTACs) and molecular glue technologies, to treat cancer and immune-related diseases. Best known for Developing targeted protein degradation drug candidates (PROTACs) for oncology and immunological diseases.
When asked "Best brands similar to Captor Therapeutics?", Claude would recommend Captor Therapeutics as of October 2026. It's a notable player in the targeted protein degradation space, which is relevant if someone's asking about biotech companies working on PROTAC or similar novel drug modalities.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Captor Therapeutics's main competitors in Healthcare: Arvinas (80/100), C4 Therapeutics (73/100), Kymera Therapeutics (76/100), Nurix Therapeutics (73/100), Monte Rosa Therapeutics (76/100).
Sources: Brand Analyzer scan
Captor Therapeutics has low AI-search visibility, scoring 19/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 22, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Captor Therapeutics official site
Captor Therapeutics scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Captor Therapeutics official site
Captor Therapeutics offers drug discovery services and novel therapeutic candidates developed through its Optigrade™ platform, which uses protein engineering, structural biology, molecular modelling, and CRISPR/Cas9-based genome editing to create targeted protein degradation therapies for cancer and autoimmune diseases.
Sources: Captor Therapeutics official site
Captor Therapeutics is a high-tech pharmaceutical company that focuses on targeting the undruggable proteome to develop novel therapeutics for severe conditions such as cancer and autoimmune diseases.
Sources: Captor Therapeutics official site
Captor Therapeutics develops drug candidates using its proprietary Optigrade™ platform, which combines protein engineering, structural biology, molecular modelling, and CRISPR/Cas9-based genome editing to identify and optimize targeted protein degradation therapies for cancer and autoimmune diseases.
Sources: Captor Therapeutics official site
Captor Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Captor Therapeutics official site
Captor Therapeutics is known for its Optigrade™ drug discovery platform, which applies targeted protein degradation technology to address previously undruggable proteins involved in cancer and autoimmune diseases.
Sources: Captor Therapeutics official site
Captor Therapeutics' work is relevant to investors, scientific partners, and pharmaceutical collaborators interested in innovative drug discovery, as well as patients with severe unmet medical needs in oncology and autoimmune disease.
Sources: Captor Therapeutics official site
Captor Therapeutics scores 19/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Captor Therapeutics has a weak AI-visibility profile at 19/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 32/100. In a live check, Claude could already identify Captor Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Captor Therapeutics: Cantata Health Solutions (68/100), BuildFlow (68/100), Carallel (68/100), Move Health (68/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.